Fitbit Flow, a low-cost, easy-to-use emergency ventilator from San Francisco-based Fitbit, has received FDA emergency use authorization for use during the COVID-19 public health emergency.
In response to the global need for ventilators, Fitbit applied its deep in-house expertise in advanced sensor development and hardware design to quickly develop Fitbit Flow, an automatic resuscitator inspired by the MIT E-Vent Design Toolbox and based on specifications for Rapidly Manufactured Ventilation Systems from the British government. During development and testing, Fitbit consulted with Oregon Health & Science University emergency medicine clinicians caring for COVID-19 patients at OHSU Hospital and worked with the Mass General Brigham Center for COVID Innovationworking group on the design to meet the needs of practitioners.
“COVID-19 has challenged all of us to push the boundaries of innovation and creativity, and use everything at our disposal to more rapidly develop products that support patients and the health care systems caring for them,” says James Park, cofounder and CEO of Fitbit. “We saw an opportunity to rally our expertise in advanced sensor development, manufacturing, and our global supply chain to address the critical and ongoing need for ventilators and help make a difference in the global fight against this virus.”
Fitbit Flow builds on standard resuscitator bags, like those used by paramedics, with sophisticated instruments, sensors, and alarms that work together to support automated compressions and patient monitoring. The device is designed to be intuitive and simple to use, potentially helping to reduce the strain on specialized staff who are typically needed to operate a commercial ventilator.
“Fitbit Flow is a great example of the incredible innovation that emerges when academia and industry employ problem-based innovation to respond quickly to an important need. COVID-19 is a new illness and we still have much to learn about the progression, treatment, and potential recurrence of this disease,” says David Sheridan, MD, MCR, assistant professor of pediatric emergency medicine and co-director of emergency clinical innovation at Oregon Health & Science University. “It’s critical that we develop solutions that can help ensure our health systems have the equipment they need now, and in the future if we do see a resurgence of COVID-19.”
Fitbit aims to leverage the company’s vast infrastructure and manufacturing capabilities that currently produces millions of Fitbit devices per year to produce large volumes of these emergency devices quickly. The goal is to supply these devices to healthcare systems around the world that do not have a sufficient number of traditional commercial ventilators. Fitbit Flow is designed to be used only when a traditional commercial ventilator is not available.
